Goldman Sachs: China Life Insurance (02628.HK) management optimistic about next year's sales momentum, hopes to provide more stable shareholder returns.

Zhitong Finance APP has learned that Goldman Sachs released a research report stating that China Life Insurance (02628, 601628.SH) management reiterated its intention to provide more stable shareholder returns over time and is optimistic about sales momentum in 2027; the bank maintains a "Neutral" rating on both H-shares and A-shares, with 12-month target prices of HK$28.5 and RMB42, respectively.